How Safe Is Johnson & Johnson's Dividend?
Johnson & Johnson (NYSE: JNJ) is one of the best-known companies in America, with most consumers making its over-the-counter products a staple of their medicine cabinets. Yet Johnson & Johnson has gotten a lot more growth from its development of key pharmaceuticals, and the company's impressive pipeline of candidate treatments and medical devices plays an important role in the future of the company.
Dividend investors have gravitated to Johnson & Johnson because of its yield and its long history of raising its quarterly payouts to shareholders for decades. Yet even J&J faces challenges that could hurt the company and its stock. Below, you'll learn more about whether Johnson & Johnson's dividend is safe for investors to count on going forward.
Metric
Source: Fool.com
Johnson & Johnson Stock
With 57 Buy predictions and not a single Sell prediction Johnson & Johnson is an absolute favorite of our community.
At the moment Johnson & Johnson has reached the predicted target price of 228 €, with a current price of 226.45 €.
